COST-EFFECTIVENESS OF A NEW FIXED-DOSE COMBINATION OF DUTASTERIDE AND TAMSULOSIN FOR THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA IN QUEBEC, CANADA

被引：0
|
作者：
Ismaila, A. [1 ]
Posnett, J. [2 ]
Walker, A. [2 ]
Sayani, A. [1 ]
Laroche, B. [3 ]
Nickel, J. C. [4 ]
Robson, R. C. [1 ]
Su, Z. [1 ]
机构：
[1] GlaxoSmithKline Inc, Mississauga, ON, Canada
[2] Heron Evidence Dev Ltd, Luton, Beds, England
[3] Hop St Francois Assise, Quebec City, PQ, Canada
[4] Queens Univ, Kingston, ON, Canada
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.1048
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A194 / A194
页数：1
相关论文
共 50 条
  • [31] Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia
    Chughtai, Bilal
    Elterman, Dean S.
    Lee, Richard
    Te, Alexis E.
    Kaplan, Steven A.
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (05) : 267 - 272
  • [32] Pharmacokinetic Bioequivalence Studies of a Fixed-Dose Combination of Tamsulosin and Dutasteride in Healthy Volunteers
    Fossler, Michael J.
    Collins, David A.
    Thompson, Meg M.
    Nino, Antonio
    Bianco, Joseph J.
    Chetty, Dushen
    CLINICAL DRUG INVESTIGATION, 2014, 34 (05) : 335 - 349
  • [33] Pharmacokinetic Bioequivalence Studies of a Fixed-Dose Combination of Tamsulosin and Dutasteride in Healthy Volunteers
    Michael J. Fossler
    David A. Collins
    Meg M. Thompson
    Antonio Nino
    Joseph J. Bianco
    Dushen Chetty
    Clinical Drug Investigation, 2014, 34 : 335 - 349
  • [34] The effect of tamsulosin and dutasteride combination drug therapy on prostate volume in patients with benign prostatic hyperplasia
    Nandana, P., I
    Adipura, L. R.
    Rasyid, H.
    3RD INTERNATIONAL CONFERENCE ON BIOSCIENCE AND BIOTECHNOLOGY, 2021, 712
  • [35] Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD
    Chan, Ming-Cheng
    Tan, Elise Chia-Hui
    Yang, Ming-Chin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 1079 - 1088
  • [36] EFFICACY AND SAFETY OF FIXED DOSE COMBINATION OF TAMSULOSIN AND TADALAFIL IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND ERECTILE DYSFUNCTION
    Kim, Sae Woong
    Jung, Jina
    Kim, Yong-Il
    Hyun, Jae Seog
    Moon, Du Geon
    Park, Nam Cheol
    Lee, Sung Won
    Kim, Soo Woong
    Ahn, Tai Young
    Moon, Ki Hak
    Min, Kweon Sik
    Ryu, Ji-Kan
    Park, Kwangsung
    Park, Jong Kwan
    Yang, Sang-Kuk
    Yang, Dae Yul
    Lee, Seung Wook
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1346 - E1346
  • [37] EFFICACY AND SAFETY OF FIXED DOSE COMBINATION OF TAMSULOSIN AND TADALAFIL IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND ERECTILE DYSFUNCTION
    Kim, S. W.
    Hyun, J. S.
    Moon, D. G.
    Park, N. C.
    Lee, S. W.
    Kim, S. W.
    Ahn, T. Y.
    Moon, K. H.
    Min, K. S.
    Ryu, J.
    Park, K.
    Park, J. K.
    Yang, S.
    Yang, D. Y.
    Lee, S. W.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (01): : S13 - S13
  • [38] Evaluation of the Cost-Effectiveness of Surgical Treatment Options for Benign Prostatic Hyperplasia
    Wymer, Kevin M.
    Narang, Gopal
    Slade, Austen
    Sharma, Vidit
    Thao, Viengneesee
    Borah, Bijan J.
    Rivera, Marcelino
    Cheney, Scott
    Humphreys, Mitchell R.
    UROLOGY, 2023, 171 : 96 - 102
  • [39] Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction
    Ahn, Sun Tae
    Lee, Dong Hyun
    Jeong, Hyeong Guk
    Kim, Jong Wook
    Oh, Mi Mi
    Park, Hong Seok
    Moon, Du Geon
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (01) : 81 - 87
  • [40] Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin
    Djavan, Bob
    Dianat, Seyed Saeid
    Kazzazi, Amir
    PATIENT-RELATED OUTCOME MEASURES, 2011, 2 : 71 - 79
12345